National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Glutaricaciduria II is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- GA II
- Glutaric Acidemia II
- Glutaric Aciduria II
- Glutaricacidemia II
- Multiple Acyl-Co-A Dehydrogenation Deficiency
- Electron Transfer Flavoprotein: Ubiquinone Oxidoreductase, Deficiency of
- Electron Transfer Flavoprotein, Deficiency of
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Glutaricaciduria I
- Medium Chain CoA Dehydrogenase Deficiency (MCAD)
Glutaricaciduria II is one of the conditions termed organic acidemias. Individuals with these conditions have a deficiency or absence of an enzyme that prevents them from breaking down certain chenicals in the body, resulting the accumulation of several organic acids in the blood and urine. Two enzymes that may be deficient in glutaricaciduria II are electron transfer flavoprotein (ETF) and ETF-ubiquinone oxidoreductase (ETF:QO). A complete enzyme deficiency causes a severe form of the disorder termed neonatal glutaricaciduria ll that is associated with a short life span and, sometimes, with specific physical birth defects. The less severe form of the disorder is termed late onset glutaricaciduria ll and has an extremely variable age of onset. Symptoms include nausea, vomiting, weakness and low blood sugar (hypoglycemia). Glutaricaciduria II is inherited as an autosomal recessive genetic disorder.
Newborns with the neonatal form of the disorder may have severe hypoglycemia, respiratory distress, low muscle tone, an odor of sweaty feet, liver abnormalities (hepatomegaly) and kidney abnormalities. Physical abnormalities are sometimes present and can include a large head (macrocephaly), high forehead, flat nasal bridge, malformed ears and genital abnormalities.
Symptoms of the late onset form of the disorder are variable and may include hypoglycemia and intermittent periods of vomiting and weakness.
Glutaricaciduria ll is caused by a deficiency or absence of enzymes that break down fats and proteins in the body, resulting in the accumulation of several organic acids in the blood and urine. Two enzymes that have been associated with glutaricaciduria II are electron transfer flavoprotein (ETF) and EFT-ubiquinone oxidoreductase (ETF:QO). Some individuals with glutaricaciduria ll have normal levels of these enzymes and the abnormal enzyme in those patients is not known.
Glutaricaciduria ll is inherited as an autosomal recessive genetic trait. Genetic diseases are determined by the combination of genes for a particular trait that are on the chromosomes received from the father and the mother.
Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.
Glutaricaciduria I is a rare hereditary metabolic disorder caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase. The disorder is characterized by decreased muscle tone (hypotonia), vomiting, and acidity of the blood. The patient may have involuntary movements of the trunk and limbs (dystonia or athetosis), and mental retardation may also occur. (For more information on this disorder, choose "glutaricaciduria I" as your search term in the Rare Disease Database.)
Medium chain CoA dehydrogenase deficiency (MCAD) is a very rare metabolic disorder characterized by a deficiency of the enzyme CoA dehydrogenase. This enzyme is needed in the breakdown (metabolism) of fats. Low blood sugar (hypoglycemia), lack of energy (lethargy) and possibly coma, associated with fatty changes in the liver, usually occur. During hypoglycemic periods, tests usually show massive amounts of dicarboxylic acid in the urine.
There are many rare disorders caused by enzyme deficiencies. To locate these disorders on the Rare Disease Database, choose "enzyme deficiency" as your search term.
The diagnosis of glutaricaciduria ll is usually made by examining urine organic acids. The characteristic pattern for glutaricaciduria is an elevation of glutaric, ethylmalonic, adipic and isovaleric acid. Some individuals with this condition are initially identified through newborn blood screening using tandem mass spectrometry for the markers C4, C5, C6, C8 and C10. Some individuals do not have an abnormal pattern of urine organic acids except when they are ill. The definitive diagnosis of glutaricaciduria ll is made by demonstrating abnormalities in ETF or ETF-QO antigens or activity in cultured fibroblast cells obtained from a skin biopsy. Prenatal diagnosis may be possible by measuring glutaric acid in amniotic fluid.
Glutaricaciduria is usually treated with a high carbohydrate, low protein and low fat diet. It is recommended that affected individuals eat often to avoid low blood sugar. Dietary supplementation with riboflavin, glycine and carnitine may be helpful.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Brusilow SW, Vallee DL. Symptomatic inborn errors of metabolism in the neonate. Current Therapy in Neonatal-Perinatal Medicine. Marcel Decker. 1985;24-27.
FROM THE INTERNET
McKusick VA. Online Mendelian Inheritance in Man, 6th ed. Johns Hopkins University Press; 1983:703,735,1038.
CLIMB (Children Living with Inherited Metabolic Diseases)
176 Nantwich Road
Crewe, CW2 6BG
Lactic Acidosis Support Trust
1A Whitley Close
Cheshire, CW10 0NQ
Organic Acidemia Association
P.O. Box 1008
Pinole, CA 94564
Organic Acidaemias UK
5, Saxon Road
Middlesex, TW15 1QL
FOD (Fatty Oxidation Disorders) Family Support Group
PO Box 54
Okemos, MI 48864
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 5/10/2008
Copyright 1987, 1988, 1990, 1992, 1997, 2004 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.